United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Technology Industry News Xerox posts steep Q3 loss, lowers 2024 revenue outlook as demand for copiers declines In a concerning turn, Xerox Holdings has reported a substantial third-quarter loss alongside a lowered revenue forecast for… byPallavi MadhirajuOctober 29, 2024